{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T04:09:13Z","timestamp":1742184553375,"version":"3.38.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,15]]},"DOI":"10.7759\/cureus.80638","type":"journal-article","created":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T05:41:56Z","timestamp":1742103716000},"source":"Crossref","is-referenced-by-count":0,"title":["The Myval Balloon-Expandable Transcatheter Heart Valve Implant in Aortic and Mitral Interventions: A Single-Center Experience"],"prefix":"10.7759","author":[{"given":"Ramesh","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav K","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai Bharat","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilip","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack MJ","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH, et al.. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019, 380:1695-705. 10.1056\/NEJMoa1814052","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura RA","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al.. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017, 135:e1159-95. 10.1161\/CIR.0000000000000503","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma JJ","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, et al.. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019, 380:1706-15. 10.1056\/NEJMoa1816885","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2022.05.006","article-title":"2021 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"75","author":"Vahanian A","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, et al.. 2021 ESC\/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Rev Esp Cardiol (Engl Ed). 2022, 75:524. 10.1016\/j.rec.2022.05.006","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2021.02.027","article-title":"Prospective evaluation of transseptal TMVR for failed surgical bioprostheses: MITRAL trial valve-in-valve arm 1-year outcomes","volume":"14","author":"Guerrero M","year":"2021","unstructured":"Guerrero M, Pursnani A, Narang A, et al.. Prospective evaluation of transseptal TMVR for failed surgical bioprostheses: MITRAL trial valve-in-valve arm 1-year outcomes. JACC Cardiovasc Interv. 2021, 14:859-72. 10.1016\/j.jcin.2021.02.027","journal-title":"JACC Cardiovasc Interv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.783507","article-title":"Transcatheter mitral valve-in-valve implantation with a new transcatheter heart valve for bioprosthetic degeneration","volume":"8","author":"Lu Y","year":"2022","unstructured":"Lu Y, Yang Y, Wang W, et al.. Transcatheter mitral valve-in-valve implantation with a new transcatheter heart valve for bioprosthetic degeneration. Front Cardiovasc Med. 2022, 8:783507. 10.3389\/fcvm.2021.783507","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-19-00413","article-title":"First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study","volume":"16","author":"Sharma SK","year":"2020","unstructured":"Sharma SK, Rao RS, Chandra P, et al.. First-in-human evaluation of a novel balloon-expandable transcatheter heart valve in patients with severe symptomatic native aortic stenosis: the MyVal-1 study. EuroIntervention. 2020, 16:421-9. 10.4244\/EIJ-D-19-00413","journal-title":"EuroIntervention"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs043","article-title":"EuroSCORE II","volume":"41","author":"Nashef SA","year":"2012","unstructured":"Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012, 41:734-44. 10.1093\/ejcts\/ezs043","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs468","article-title":"EuroSCORE II and the art and science of risk modelling","volume":"43","author":"Nashef SA","year":"2013","unstructured":"Nashef SA, Sharples LD, Roques F, Lockowandt U. EuroSCORE II and the art and science of risk modelling. Eur J Cardiothorac Surg. 2013, 43:695-6. 10.1093\/ejcts\/ezs468","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"22","author":"Baumgartner H","year":"2009","unstructured":"Baumgartner H, Hung J, Bermejo J, et al.. Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009, 22:1-23; quiz 101-2. 10.1016\/j.echo.2008.11.029","journal-title":"J Am Soc Echocardiogr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivt132","article-title":"The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase","volume":"17","author":"Hemmann K","year":"2013","unstructured":"Hemmann K, Sirotina M, De Rosa S, et al.. The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg. 2013, 17:359-64. 10.1093\/icvts\/ivt132","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000932","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"143","author":"Otto CM","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, et al.. 2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021, 143:e35-71. 10.1161\/CIR.0000000000000932","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for cardiovascular magnetic resonance","volume":"30","author":"Zoghbi WA","year":"2017","unstructured":"Zoghbi WA, Adams D, Bonow RO, et al.. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for cardiovascular magnetic resonance. J Am Soc Echocardiogr. 2017, 30:303-71. 10.1016\/j.echo.2017.01.007","journal-title":"J Am Soc Echocardiogr"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175210","article-title":"Transcatheter mitral valve-in-valve implantation with the balloon-expandable Myval device","volume":"11","author":"Blasco-Turri\u00f3n S","year":"2022","unstructured":"Blasco-Turri\u00f3n S, Serrador-Frutos A, Jose J, et al.. Transcatheter mitral valve-in-valve implantation with the balloon-expandable Myval device. J Clin Med. 2022, 11:10.3390\/jcm11175210","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2018.01.001","article-title":"Antithrombotic therapy in TAVI","volume":"15","author":"Vavuranakis M","year":"2018","unstructured":"Vavuranakis M, Kalogeras K, Kolokathis AM, et al.. Antithrombotic therapy in TAVI. J Geriatr Cardiol. 2018, 15:66-75. 10.11909\/j.issn.1671-5411.2018.01.001","journal-title":"J Geriatr Cardiol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15420\/icr.2020.32","article-title":"Myval: a novel transcatheter heart valve for the treatment of severe aortic stenosis","volume":"18","author":"Seth A","year":"2023","unstructured":"Seth A, Kumar V, Singh VP, Kumar D, Varma P, Rastogi V. Myval: a novel transcatheter heart valve for the treatment of severe aortic stenosis. Interv Cardiol. 2023, 18:e12. 10.15420\/icr.2020.32","journal-title":"Interv Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2024.03.034","article-title":"Predictors and 5-year clinical outcomes of pacemaker after TAVR: analysis from the PARTNER 2 SAPIEN 3 registries","volume":"17","author":"Chen S","year":"2024","unstructured":"Chen S, Dizon JM, Hahn RT, et al.. Predictors and 5-year clinical outcomes of pacemaker after TAVR: analysis from the PARTNER 2 SAPIEN 3 registries. JACC Cardiovasc Interv. 2024, 17:1325-36. 10.1016\/j.jcin.2024.03.034","journal-title":"JACC Cardiovasc Interv"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.06.159","article-title":"Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: a meta-analysis","volume":"220","author":"Ando T","year":"2016","unstructured":"Ando T, Briasoulis A, Holmes AA, Taub CC, Takagi H, Afonso L. Sapien 3 versus Sapien XT prosthetic valves in transcatheter aortic valve implantation: a meta-analysis. Int J Cardiol. 2016, 220:472-8. 10.1016\/j.ijcard.2016.06.159","journal-title":"Int J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.07.006","article-title":"Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival","volume":"221","author":"Takagi H","year":"2016","unstructured":"Takagi H, Umemoto T. Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. Int J Cardiol. 2016, 221:46-51. 10.1016\/j.ijcard.2016.07.006","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/345737-the-myval-balloon-expandable-transcatheter-heart-valve-implant-in-aortic-and-mitral-interventions-a-single-center-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,16]],"date-time":"2025-03-16T05:42:02Z","timestamp":1742103722000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/345737-the-myval-balloon-expandable-transcatheter-heart-valve-implant-in-aortic-and-mitral-interventions-a-single-center-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.80638","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,15]]}}}